Projects per year
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Neoplasms
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Italy
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Melanoma
Medicine & Life Sciences
docetaxel
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 2018 2018
- 4 Finished
Istituto Scientifico Romagnolo - GENETICA E AMBIENTE NELLO SVILUPPO E PROGRESSIONE DEI TUMORI E MECCANISMI INIBITORI. EXPOSOMICA, PREVENZIONE PRIMARIA E SECONDARIA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
Istituto Scientifico Romagnolo - TERAPIE INNOVATIVE, TRIALS DI FASE I-III E DI STRATEGIA TERAPEUTICA BASATI SU MODELLI PRECLINICI, MECCANISMI ONCO-IMMUNOLOGICI, NANOVETTORI
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
Istituto Scientifico Romagnolo - APPROPRIATEZZA, ESITI, VALUE DEL FARMACO E MODELLI ORGANIZZATIVI FUNZIONALI ALLA CONTINUITA' DEI PERCORSI DIAGNOSTICO-TERAPEUTICI IN ONCOLOGIA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
Research Output 1965 2019
Aneuploidy: Cancer strength or vulnerability?
Simonetti, G., Bruno, S., Padella, A., Tenti, E. & Martinelli, G., Jan 1 2019, In : International Journal of Cancer. 144, 1, p. 8-25 18 p.Research output: Contribution to journal › Review article
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients
Del Re, M., Cinieri, S., Michelucci, A., Salvadori, S., Loupakis, F., Schirripa, M., Cremolini, C., Crucitta, S., Barbara, C., Di Leo, A., Latiano, T. P., Pietrantonio, F., Di Donato, S., Simi, P., Passardi, A., De Braud, F., Altavilla, G., Zamagni, C., Bordonaro, R., Butera, A. & 6 others , Jan 1 2019, In : Pharmacogenomics Journal.Research output: Contribution to journal › Article
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., Roca, E. & 2 others , Jan 8 2019, In : British Journal of Cancer. 120, 1, p. 57-62 6 p.Research output: Contribution to journal › Article